Human Ace2 Receptor | List of Frontiers open access articles

Original Research

Published on 08 Jun 2022

Deciphering the Impact of Mutations on the Binding Efficacy of SARS-CoV-2 Omicron and Delta Variants With Human ACE2 Receptor

in Chemical Biology

Alamgir Khan
Salman Ali Khan
Komal Zia
Mezna Saleh Altowyan
Assem Barakat
Zaheer Ul-Haq

Frontiers in Chemistry

doi 10.3389/fchem.2022.892093

4,474 views
21 citations

Original Research

Published on 05 Jan 2024

Evaluating the Spike–hACE2 interactions in the wild type and variants of concern of SARS -CoV-2 at different temperatures

in Biophysics

Nabanita Mandal
Soumya Lipsa Rath

Frontiers in Physics

doi 10.3389/fphy.2023.1320437

2,744 views

Original Research

Published on 08 Dec 2022

Identification of potential inhibitors of omicron variant of SARS-Cov-2 RBD based virtual screening, MD simulation, and DFT

in Theoretical and Computational Chemistry

Xudong Lü
Cuiyue Feng
Ruijie Lü
Xiyu Wei
Shuai Fan
Maocai Yan
Xiandui Zhu
Zhifei Zhang
Zhaoyong Yang

Frontiers in Chemistry

doi 10.3389/fchem.2022.1063374

3,738 views
4 citations

Original Research

Published on 12 Aug 2021

DNA Aptamers Block the Receptor Binding Domain at the Spike Protein of SARS-CoV-2

in Biological Modeling and Simulation

Fabrizio Cleri
Marc F. Lensink
Ralf Blossey

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2021.713003

8,946 views
26 citations

Original Research

Published on 24 Oct 2023

Exploring the disruption of SARS-CoV-2 RBD binding to hACE2

in Theoretical and Computational Chemistry

Camryn Carter
Justin Airas
Haley Gladden
Bill R. Miller
Carol A. Parish

Frontiers in Chemistry

doi 10.3389/fchem.2023.1276760

3,734 views
3 citations

Original Research

Published on 27 Jun 2023

Differences in the organization of interface residues tunes the stability of the SARS-CoV-2 spike-ACE2 complex

in Biological Modeling and Simulation

Mattia Miotto
Lorenzo Di Rienzo
Greta Grassmann
Fausta Desantis
Gianluca Cidonio
Giorgio Gosti
Marco Leonetti
Giancarlo Ruocco
Edoardo Milanetti

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1205919

2,507 views
7 citations

Original Research

Published on 15 Jul 2024

MGPPI: multiscale graph neural networks for explainable protein–protein interaction prediction

in Computational Genomics

Shiwei Zhao
Zhenyu Cui
Gonglei Zhang
Yanlong Gong
Lingtao Su

Frontiers in Genetics

doi 10.3389/fgene.2024.1440448

4,410 views
3 citations

Mini Review

Published on 28 Nov 2022

Potential use of the S-protein–Angiotensin converting enzyme 2 binding pathway in the treatment of coronavirus disease 2019

in Infectious Diseases: Epidemiology and Prevention

Long Feng
Shihui Fu
Pei Zhang
Yujie Zhang
Yali Zhao
Yao Yao
Leiming Luo
Ping Ping

Frontiers in Public Health

doi 10.3389/fpubh.2022.1050034

4,394 views
1 citation

Original Research

Published on 11 Jun 2021

Expression of Human ACE2 N-terminal Domain, Part of the Receptor for SARS-CoV-2, in Fusion With Maltose-Binding Protein, E. coli Ribonuclease I and Human RNase A

in Virology

Shuang-yong Xu
Alexey Fomenkov
Tien-Hao Chen
Erbay Yigit

Frontiers in Microbiology

doi 10.3389/fmicb.2021.660149

5,664 views
3 citations

Original Research

Published on 29 Jul 2021

Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity

in Vaccines and Molecular Therapeutics

Antonella Scaglione
Silvana Opp
Alicia Hurtado
Ziyan Lin
Christine Pampeno
Maria G. Noval
Sara A. Thannickal
Kenneth A. Stapleford
Daniel Meruelo

Frontiers in Immunology

doi 10.3389/fimmu.2021.719077

7,075 views
18 citations

Original Research

Published on 04 Mar 2021

1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection

in Ethnopharmacology

Rui Hong Chen
Li Jun Yang
Sami Hamdoun
Sookja Kim Chung
Christopher Wai-kei Lam
Kai Xi Zhang
Xiaoling Guo
Chenglai Xia
Betty Yuen Kwan Law
Vincent Kam Wai Wong

Frontiers in Pharmacology

doi 10.3389/fphar.2021.634176

9,627 views
55 citations

Methods

Published on 15 Jan 2021

Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol

in Cardiovascular Metabolism

Jose Manuel Condor Capcha
Guerline Lambert
Derek M. Dykxhoorn
Alessandro G. Salerno
Joshua M. Hare
Michael A. Whitt
Savita Pahwa
Dushyantha T. Jayaweera
Lina A. Shehadeh

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2020.618651

46,843 views
78 citations

Original Research

Published on 11 Dec 2023

Inducing enhanced neutralizing antibodies against broad SARS-CoV-2 variants through glycan-shielding multiple non-neutralizing epitopes of RBD

in Vaccines and Molecular Therapeutics

Qingyun Zhang
Yi Yang
Jun Lan
Ziyi Wang
Yan Gao
Xiao Li
Weidong Mao
Jing Xie
Li-Zhi Mi
Xiangyang Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1259386

3,729 views
4 citations

Original Research

Published on 28 Apr 2021

Pomegranate Peel Extract as an Inhibitor of SARS-CoV-2 Spike Binding to Human ACE2 Receptor (in vitro): A Promising Source of Novel Antiviral Drugs

in Chemical Biology

Annalisa Tito
Antonio Colantuono
Luciano Pirone
Emilia Pedone
Daniela Intartaglia
Giuliana Giamundo
Ivan Conte
Paola Vitaglione
Fabio Apone

Frontiers in Chemistry

doi 10.3389/fchem.2021.638187

50,365 views
95 citations

Original Research

Published on 05 Apr 2024

Identification and characterization of endogenous retroviruses upon SARS-CoV-2 infection

in Viral Immunology

Xuefei Guo
Yang Zhao
Fuping You

Frontiers in Immunology

doi 10.3389/fimmu.2024.1294020

8,034 views
14 citations

Articles

Deciphering the Impact of Mutations on the Binding Efficacy of SARS-CoV-2 Omicron and Delta Variants With Human ACE2 Receptor

Evaluating the Spike–hACE2 interactions in the wild type and variants of concern of SARS -CoV-2 at different temperatures

Identification of potential inhibitors of omicron variant of SARS-Cov-2 RBD based virtual screening, MD simulation, and DFT

DNA Aptamers Block the Receptor Binding Domain at the Spike Protein of SARS-CoV-2

Exploring the disruption of SARS-CoV-2 RBD binding to hACE2

Differences in the organization of interface residues tunes the stability of the SARS-CoV-2 spike-ACE2 complex

MGPPI: multiscale graph neural networks for explainable protein–protein interaction prediction

Potential use of the S-protein–Angiotensin converting enzyme 2 binding pathway in the treatment of coronavirus disease 2019

Expression of Human ACE2 N-terminal Domain, Part of the Receptor for SARS-CoV-2, in Fusion With Maltose-Binding Protein, E. coli Ribonuclease I and Human RNase A

Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity

1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection

Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol

Inducing enhanced neutralizing antibodies against broad SARS-CoV-2 variants through glycan-shielding multiple non-neutralizing epitopes of RBD

Pomegranate Peel Extract as an Inhibitor of SARS-CoV-2 Spike Binding to Human ACE2 Receptor (in vitro): A Promising Source of Novel Antiviral Drugs

Identification and characterization of endogenous retroviruses upon SARS-CoV-2 infection